Author | Valentin Goede, MD | OncLive

Author | Valentin Goede, MD


Dr. Goede on Obinutuzumab Versus Rituximab in CLL

December 08, 2013


Valentin Goede, MD, from the University Hospital Cologne, discusses the efficacy findings from the stage 2 CLL11 study that examined obinutuzumab plus chlorambucil in patients with chronic lymphocytic leukemia with comorbidities.

Dr. Goede on the Results from the Phase III CLL11 Trial

June 19, 2013


Valentin Goede, MD, Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, University of Cologne, Germany, discusses the findings of the phase III CLL11 trial.